Tafamidis reduces disease progression in patients with transthyretin familial amyloid polyneuropathy: supportive post-hoc analyses of a pivotal trial

समान संसाधन

• Early intervention with tafamidis provides long-term benefit in delaying neurological progression in patients with transthyretin familial amyloid polyneuropathy
  द्वारा: Waddington-Cruz, Marcia, और अन्य
  प्रकाशित: (2015)
• Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
  द्वारा: Leslie Amass, और अन्य
  प्रकाशित: (2018-12-01)
• Influence of baseline neurologic severity on disease progression and the associated disease-modifying effects of tafamidis in patients with transthyretin amyloid polyneuropathy
  द्वारा: Amass, Leslie, और अन्य
  प्रकाशित: (2018)
• Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy
  द्वारा: Waddington Cruz, Márcia, और अन्य
  प्रकाशित: (2016)
• Positive real-world effectiveness of tafamidis for delaying disease progression in transthyretin familial amyloid polyneuropathy
  द्वारा: Stewart, Michelle, और अन्य
  प्रकाशित: (2015)